Liminal Biosciences Inc (LMNL)
8.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 26, 16:00
Liminal Biosciences Market Cap: 27.62M for Sept. 26, 2023
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 26, 2023 | 27.62M |
| September 25, 2023 | 27.62M |
| September 22, 2023 | 27.59M |
| September 21, 2023 | 27.56M |
| September 20, 2023 | 27.52M |
| September 19, 2023 | 27.52M |
| September 18, 2023 | 27.52M |
| September 15, 2023 | 27.52M |
| September 14, 2023 | 27.49M |
| September 13, 2023 | 27.43M |
| September 12, 2023 | 27.36M |
| September 11, 2023 | 27.33M |
| September 08, 2023 | 27.36M |
| September 07, 2023 | 27.39M |
| September 06, 2023 | 27.35M |
| September 05, 2023 | 27.39M |
| September 01, 2023 | 27.43M |
| August 31, 2023 | 27.33M |
| August 30, 2023 | 27.39M |
| August 29, 2023 | 27.36M |
| August 28, 2023 | 27.36M |
| August 25, 2023 | 27.37M |
| August 24, 2023 | 27.36M |
| August 23, 2023 | 27.33M |
| August 22, 2023 | 27.28M |
| Date | Value |
|---|---|
| August 21, 2023 | 27.28M |
| August 18, 2023 | 27.22M |
| August 17, 2023 | 27.23M |
| August 16, 2023 | 27.20M |
| August 15, 2023 | 27.20M |
| August 14, 2023 | 27.20M |
| August 11, 2023 | 27.20M |
| August 10, 2023 | 27.20M |
| August 09, 2023 | 27.23M |
| August 08, 2023 | 27.20M |
| August 07, 2023 | 27.20M |
| August 04, 2023 | 27.23M |
| August 03, 2023 | 27.23M |
| August 02, 2023 | 27.20M |
| August 01, 2023 | 27.20M |
| July 31, 2023 | 27.23M |
| July 28, 2023 | 27.23M |
| July 27, 2023 | 27.20M |
| July 26, 2023 | 27.23M |
| July 25, 2023 | 27.17M |
| July 24, 2023 | 27.20M |
| July 21, 2023 | 27.20M |
| July 20, 2023 | 27.17M |
| July 19, 2023 | 27.17M |
| July 18, 2023 | 27.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.09M
Minimum
Dec 30 2022
1.094B
Maximum
Apr 24 2019
138.96M
Average
123.97M
Median
Mar 24 2021
Market Cap Benchmarks
| Acasti Pharma Inc | 25.38M |
| Aurinia Pharmaceuticals Inc | 1.149B |
| Edesa Biotech Inc | 17.03M |
| Lexaria Bioscience Corp | 8.015M |
| Xenon Pharmaceuticals Inc | 2.261B |
Market Cap Related Metrics
| PE Ratio | 31.76 |
| PS Ratio | 72.58 |
| Price to Book Value | 1.704 |
| Price | 8.50 |
| Earnings Yield | 3.15% |